CTYPE html> BacVacDB | Bacterial Diseases

Browse By Bacterial Diseases

This page shows data for Pneumococcal disease.
Total Entries Retrieved: 15
IDName of the vaccineDisease nameName of bacteriaType of vaccineName of the manufacturerClinical Phase statusRoute of administrationPubMed identifierClinical trial number
1139 Prevnar 20 Pneumococcal Streptococcus pneumoniae Conjugate Pfizer Approved Intramuscular NA NA
1140 Prevnar 13 Pneumococcal Streptococcus pneumoniae Inactivated Pfizer Approved Intramuscular NA NA
1141 Prevnar Pneumococcal Streptococcus pneumoniae Inactivated Wyeth Pharmaceuticals Inc. Approved Intramuscular NA NA
1142 Pneumovax 23 Pneumococcal Streptococcus pneumoniae Polysaccharide Merck & Co. Approved Intramuscular NA NA
1143 VAXNEUVANCE Pneumococcal Streptococcus pneumoniae Conjugate Merck Sharp & Dohme Corp. Approved Intramuscular NA NA
1144 Synflorix Pneumococcal Streptococcus pneumoniae Conjugate GlaxoSmithKline Biologicals Approved Intramuscular NA NA
1145 Pneumosil Pneumococcal Streptococcus pneumoniae Conjugate By collaboration between Serum Institute of India Pvt Ltd and PATH. Approved Intramuscular NA NA
1342 ProDiax-23 Pneumococcal Streptococcus pneumoniae Polysaccharide Korea University Guro Hospital Clinical - Phase 4 Intramuscular NA NCT04875858
1343 V114 Pneumococcal Streptococcus pneumoniae Conjugate Merck Sharp & Dohme Corp. Clinical - Phase 3 Intramuscular NA NCT03547167
1344 NBP606 Pneumococcal Streptococcus pneumoniae Conjugate SK Chemicals Co., Ltd. Clinical - Phase 3 Intramuscular NA NCT02201030
1345 PCV13i Pneumococcal Streptococcus pneumoniae Conjugate CanSino Biologics Inc. Clinical - Phase 3 Intramuscular NA NCT04841369
1346 GSK513026 Pneumococcal Streptococcus pneumoniae NA GlaxoSmithKline Clinical - Phase 2 Intramuscular NA NCT00307528
1347 LBVE Pneumococcal Streptococcus pneumoniae Conjugate LG Chem Clinical - Phase 2 Intramuscular NA NCT03467984
1348 PNCRM9 Pneumococcal Streptococcus pneumoniae Conjugate National Institute of Allergy and Infectious Diseases (NIAID) Clinical - Phase 2 Intramuscular NA NCT00133549
1349 GEN-004 Pneumococcal Streptococcus pneumoniae Subunit Genocea Biosciences, Inc. Clinical - Phase 2 Intramuscular NA NCT02116998